Cite
MLA Citation
B. Wortman et al.. “Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy.” British journal of cancer, vol. 119, no. 9, 2018, pp. 1067–1074. http://access.bl.uk/ark:/81055/vdc_100086829791.0x0001aa